The DETERMINE study aims to use genetic testing to match children, teenagers and adults with rare cancers to existing targeted…
Using NCRI data to develop a blood cancer research strategy
'Blood Cancer UK used NCRI Cancer Research Database (CaRD) data to inform their research strategy, to set a plan for…
NCRI Group members challenging the status quo in brain tumour research
'Members of the NCRI Brain Group have published a position statement arguing that there is not enough evidence to support…
Using online symptom reporting to manage cancer symptoms
'A trial has found that cancer patients can benefit from regular online symptom reporting combined with a computer algorithm to…
Supporting the development of high-quality research by providing expert guidance
'NCRI’s proposals guidance helps investigators develop ideas for cancer research studies and progress them into applications ready for funding. Researchers…
Identifying lymphoma treatment response using molecular profiling
'Diffuse large B cell lymphoma (DLBCL) is an aggressive B cell malignancy and the most common type of non-Hodgkin lymphoma.…
Study identifies challenges in involving young people in research
'Evaluating specialist care for young people with cancer was identified as a research priority by the NCRI Teenage and Young…
Developing one of the most extensive global studies of lung cancer patients
'Could tumour diversity be resulting in poor treatment outcomes? Despite many years of clinical research into lung cancer, the outcomes…
Making informed decisions in the event of myeloma relapse
'Treating relapsed myeloma Around 5,700 people are diagnosed with myeloma in the UK each year. As there is no cure…
Establishing a resource for chronic lymphocytic leukaemia researchers
'Biobanks give researchers access to biological material and clinical data on a scale that individual researchers would not be able…
Accurate detection of prostate cancer and the crucial role of patient involvement
'The Prostagram trial investigated the use of MRI scans to detect prostate cancer. At present, there is no nationally approved…
Could drug treatment combined with targeted radiotherapy improve brain mets prognosis?
'Patients with brain metastases are an underserved population Brain metastases occur in 20-40% of all patients with cancer. Brain metastases…